Results 71 to 80 of about 131,242 (269)

Beyond right or wrong: How partial credit scoring on multiple‐choice questions improves student performance and assessment perceptions

British Journal of Clinical Pharmacology, EarlyView.
Aims In this study, we examined the effects of assigning partial credit to selected answer choices on student performance and perceptions in a pharmacology course using Type A multiple‐choice questions (MCQs). Methods Partial credit scoring was incorporated into quizzes and exams in a 10‐week pharmacology course for postbaccalaureate premedical ...
Stephen D. Schneid, Chris Armour, Katharina Brandl   +2 more
wiley   +1 more source

Abnormal late postprandial glucagon response in type 1 diabetes is a function of differences in stimulated C-peptide concentrations

Frontiers in Endocrinology
BackgroundThe functional changes in alpha cells in patients with type 1 diabetes (T1D) with different residual beta cell functions remain poorly elucidated.
Lingyu Zhang, Lingyu Zhang, Yao Qin, Yiting Huang, Qizhen Hu, Qian Wu, Xing Wang, Mei Zhang   +7 more
doaj   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Disorders

, 2022
Jothydev Kesavadev, Rajiv Kovil, Debasis Basu, Soumyabrata Roy Chaudhuri, Mithun Bhartia   +4 more
openalex   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Pharmacokinetics, pharmacodynamics and safety of vutiglabridin after multiple oral administrations in healthy female and obese subjects

British Journal of Clinical Pharmacology, EarlyView.
Aims Vutiglabridin (HSG4112) is a novel drug under clinical development for antiobesity treatment. This study aimed to evaluate the pharmacokinetics (PKs) and safety of vutiglabridin after multiple oral administrations in healthy Korean female and obese subjects and explore short‐term pharmacodynamic (PD) responses.
Sooyoun Lee, Hyun Chul Kim, Young Ran Yoon, In‐Jin Jang, Sang‐Ku Yoo, Kyung‐Sang Yu   +5 more
wiley   +1 more source

Possible role of endogenous prostaglandins in glucagon secretion by isolated guinea-pig islets [PDF]

, 1978
A Luyckx, Pierre J. Lefèbvre
openalex   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Conservative Management of Common Bile Duct Stones Post-Sleeve Gastrectomy: A Case Report on the Role of Glucagon and Subsequent Laparoscopic Cholecystectomy

Dr. Sulaiman Al Habib Medical Journal
Obesity is a significant global health concern, leading to the widespread adoption of bariatric procedures such as laparoscopic sleeve gastrectomy (LSG).
Dani Osman, Etienne El-Helou, Mohamed Imad Abdelrhim Hassan, Hassan Marwan Hassan Ahmed, Wadah Yasin Deba, Ahmed Magdy Saleh Mohamed, Feras Al Rawashdeh, Nasser Alrashidi   +7 more
doaj   +1 more source

Effects of glucagon on fructose-induced alterations of glucose metabolism in man [PDF]

, 1996
Nicolas Paquot, P. Schneiter, E Jéquier, Luc Tappy   +3 more
openalex   +1 more source

The effectiveness of the glucagon‐like peptide 1 receptor agonist in improving cognitive function [PDF]

, 2023
Naoise Rasmussen, Richéal Burns, Karen Coughlan   +2 more
openalex   +1 more source